Biogen Idec, Inc. (BIIB) Reports Solid Q2 Results

July 24, 2012 7:00 AM EDT Send to a Friend
Get Alerts BIIB Hot Sheet
Trade BIIB Now!
Join SI Premium – FREE
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $1.82, $0.26 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.33 billion.

For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment